Abstract:Background: Ornithine carbamoyltransferase deficiency (OTCD) is a kind of X-linked metabolic disease caused by a deficiency in ornithine transcarbamylase leading to urea cycle disorders. The main reason is that the OTC gene variants lead to the loss or decrease of OTC enzyme function, which hinders the ammonia conversion to urea, resulting in hyperammonemia and severe neurological dysfunction. Here, we studied one Chinese family of three generations who consecutively gave birth to two babies with OTCD. This study aims to explore the pathogenicity of two missense variants in the OTC gene and investigate the application of preimplantation genetic testing for monogenic (PGT-M) for a family troubled by Ornithine carbamoyltransferase deficiency (OTCD). Methods: The retrospective method was used to classify the pathogenicity of two missense variants in the OTC gene in a family tortured by OTCD. Sanger sequencing was used to validate the variants in the OTC gene, and then the pathogenicity of variants was confirmed through family analysis and bioinformatics software. We used PGT-M to target the OTC gene and select a suitable embryo for transplantation. Prenatal diagnosis was recommended to confirm previous results using Sanger sequencing and karyotyping at an appropriate gestational stage. Tandem mass spectrometry (MS-MS) and gas chromatography-mass spectrometry (GC-MS) were used to detect fetal metabolism after birth. The number of the study cohort is ChiCTR2100053616. Results: Two missense variants, c.959G > C (p.Arg320Pro) and c.634G > A (p.Gly212Arg), were validated in the OTC gene in this family. According to the ACMG genetic variation classification criteria, the missense variant c.959G > C can be considered as "pathogenic", and the missense variant c.634G > A can be regarded as "likely benign." PGT-M identified a female embryo carrying the heterozygous variant c.959G > C (p.Arg320Pro), which was selected for transplantation. Prenatal diagnosis revealed the same variant in the fetus, and continued pregnancy was recommended. A female baby was born, and her blood amino acid testing and urine organic acid testing were regular. Follow-up was conducted after six months and indicated the girl was healthy. Conclusion: Our research first validated the segregation of both c.959G > C and c.634G > A variants in the OTC gene in a Chinese OTCD family. Then, we classified variant c.959G > C as "pathogenic" and variant c.634G > A as "likely benign", providing corresponding theoretical support for genetic counseling and fertility guidance in this family. PGT-M and prenatal diagnosis were recommended to help the couple receive a female baby successfully with a six-month follow-up.

Mild Phenotypes of Gyrate Atrophy in a Heterozygous Carrier with One Variant Allele of OAT

Diagnostic Value of a Combination of Next-Generation Sequencing, Chorioretinal Imaging and Metabolic Analysis: Lessons from a Consanguineous Chinese Family with Gyrate Atrophy of the Choroid and Retina Stemming from a Novel OAT Variant

A Novel OPA1 Mutation in a Chinese Family with Autosomal Dominant Optic Atrophy

Mutation of CRYAB Encoding a Conserved Mitochondrial Chaperone and Anti-Apoptotic Protein Causes Hereditary Optic Atrophy.

Extending diagnostic practices in gyrate atrophy: Enzymatic characterization and the development of an in vitro pyridoxine responsiveness assay

The mitochondrial tRNAThr A15951G mutation may influence the phenotypic expression of the LHON-associated ND4 G11778A mutation in a Chinese family

Novel ATF6 Homozygous Variant in a Chinese Patient with Achromatopsia.

The mitochondrial tRNAGlu A14693G mutation may influence the phenotypic manifestation of ND1 G3460A mutation in a Chinese family with Leber’s hereditary optic neuropathy

Mitochondrial ND6 T14502C Variant May Modulate the Phenotypic Expression of LHON-associated G11778A Mutation in Four Chinese Families.

Finnish gyrate atrophy mutation OAT;c.1205C>T leads to accumulation of intracellular GABA

Clinical characteristics of gyrate atrophy compared with a gyrate atrophy-like retinal phenotype

Gyrate Atrophy of the Choroid and Retina: A Review

A cohort study of 19 patients with gyrate atrophy of the choroid and retina (GACR)

Biochemical Studies on Human Ornithine Aminotransferase Support a Cell-Based Enzyme Replacement Therapy in the Gyrate Atrophy of the Choroid and Retina

Variant analysis and PGT-M of OTC gene in a Chinese family with ornithine carbamoyltransferase deficiency

A recurrent deletion mutation in OPA1 causes autosomal dominant optic atrophy in a Chinese family

Pathogenicity Evaluation and the Genotype–phenotype Analysis of OPA1 Variants

Multimodal imaging and genetic screening in Mexican patients with Gyrate atrophy: identification of novel OAT pathogenic variants

Optic Atrophy and Sensorineural Hearing Loss in a Family Caused by an R445H OPA1 Mutation.

Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy.

Identification of Two Novel OPA1 Mutations in Chinese Families with Autosomal Dominant Optic Atrophy.